Health Alert: Recall of Specific Children’s Cough and Cold Medicines in India
The Government of India has recalled several children’s cough and cold medicines due to potential contamination with diethylene glycol (DEG) and ethylene glycol (EG). These substances can be toxic and pose serious health risks.
The following products have been recalled in India:
- Coldrif, manufactured by Sresan Pharmaceuticals
- Re-Life Syrup, manufactured by Shape Pharma Pvt. Ltd.
- Respifresh-TR, manufactured by Rednex Pharmaceuticals Pvt. Ltd.
- Dextromethorphan Hydrobromide Syrup, manufactured by Kaysons Pharma Ltd.
For more information, including product images, visit the U.S. Food & Drug Administration’s notice on actions to protect children from contaminated cough medicine that was published on October 10, 2025:
https://www.fda.gov/drugs/drug-safety-and-availability/fdas-actions-protect-children-contaminated-cough-medicine
Assistance:
U.S. Embassy in New Delhi
Shantipath, Chanakyapuri
New Delhi – 110021
+91-11-2419-8000
ACSND@state.gov
U.S. Consulate General in Mumbai
C-49, G-Block, Bandra Kurla Complex
Bandra East, Mumbai, 400051
+91 22-2672-4000
MumbaiACS@state.gov
U.S. Consulate General in Chennai
220 Anna Salai, Gemini Circle
Chennai 600006
+91-44-2857-4000
ChennaiCS@state.gov
U.S. Consulate General in Hyderabad
Survey No. 115/1
Financial District, Nanakramguda
Hyderabad, Telangana, 500032
+91-40-6932-8000
HydACS@state.gov
U.S. Consulate General in Kolkata
5/1 Ho Chi Minh Sarani
Kolkata – 700071
West Bengal, India
+91-33-3984-2400
KolkataACS@state.gov
State Department – Consular Affairs
888-407-4747 or 202-501-4444
India Country Information
Enroll in the Smart traveler Enrollment Program (STEP) to receive security updates.
